TickerFactsScreenerDevelopers

Bionano Genomics, Inc. (BNGO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$20.82M2018: -$19.94M2019: -$29.53M2020: -$38.31M2021: -$71.93M2022: -$124.82M2023: -$125.18M2024: -$68.92M2025: -$16.34M-$16.34M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$16.34M+76.3%
2024-$68.92M+44.9%
2023-$125.18M-0.3%
2022-$124.82M-73.5%
2021-$71.93M-87.7%
2020-$38.31M-29.7%
2019-$29.53M-48.1%
2018-$19.94M+4.2%
2017-$20.82M—